Clinical Trial

Comparison of NEWS2 and Machine Learning for Early Sepsis Warning

Study acronym: SEW-ML
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This prospective observational study aims to objectively measure the lead-time (the time from the first KDS alert to sepsis diagnosis) of the NEWS2-based clinical decision support system (KDS) and compare its early warning performance with a machine learning model trained on 2000 patients and externally validated. The study seeks to answer the following main questions: How early does the NEWS2-based KDS provide an alert before sepsis diagnosis? Does a machine learning model, developed using logistic regression and externally validated in a prospective cohort, offer superior specificity and comparable sensitivity to KDS? Participants who are already receiving routine clinical care at Kocaeli City Hospital will have their vital signs and laboratory data monitored as part of standard practice. NEWS2 scores will be calculated automatically and the time of the first alert (T0) will be recorded. Sepsis diagnosis will be confirmed by an increase in SOFA score ≥ 2 (T1), evaluated by two independent and blinded physicians. Lead-time will be calculated as the difference between T1 (hours×60) and T0 (minutes). The machine learning model will be tested prospectively on this cohort, and its performance will be compared with KDS using sensitivity, specificity, F1 score, ROC-AUC, and accuracy.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-08-14
critical Primary endpoint(s) modified 2026-08-14
Trial Details
NCT Number NCT07734480
Lead Sponsor Kocaeli Derince Education and Research Hospital
Conditions Sepsis, News-2, Machine Learning
Enrollment 100 participants
Start Date 2026-07-22
Primary Completion 2026-08-11 (estimated)
Study Completion 2026-08-13 (estimated)
Updated on ClinicalTrials.gov 2026-08-13